N-(3-(Benzo[d]thiazol-2-yl)-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)-2-(4-chlorophenoxy)acetamide hydrochloride

Catalog No. :
ACDDXK969
CAS No. :
1216456-19-7
Molecular Formula :
C29H25Cl2N3O2S2
Molecular Weight :
582.58

IUPAC Name:N-(3-(benzo[d]thiazol-2-yl)-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)-2-(4-chlorophenoxy)acetamide hydrochloride

N-(3-(Benzo[d]thiazol-2-yl)-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)-2-(4-chlorophenoxy)acetamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-(Benzo[d]thiazol-2-yl)-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)-2-(4-chlorophenoxy)acetamide hydrochloride
IUPAC NameN-(3-(benzo[d]thiazol-2-yl)-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)-2-(4-chlorophenoxy)acetamide hydrochloride
Molecular FormulaC29H25Cl2N3O2S2
Molecular Weight582.58
SMILESO=C(NC(S1)=C(C2=NC3=CC=CC=C3S2)C4=C1CN(CC5=CC=CC=C5)CC4)COC6=CC=C(Cl)C=C6.[H]Cl
InChI KeyMCXTUVFYPPBURV-UHFFFAOYSA-N
SynonymN-(3-(benzo[d]thiazol-2-yl)-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)-2-(4-chlorophenoxy)acetamide hydrochloride
CAS No.1216456-19-7

Synthetic Route by SureRoute

1. ACDDXK969 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIREQ137 route compound structure diagram
    ACIREQ13713730-98-8 In Stock
  4. Then
  5. ACDDXK969 route product structure diagram
    ACDDXK9691216456-19-7
Inquiry

2. ACDDXK969 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDDXK969 route product structure diagram
    ACDDXK9691216456-19-7
Inquiry

Comments (0)